Physician profile
Ferando Daniel Testai
NPI 1114124278
$766.65
in general payments reported to CMS, 2019-2025
5 companies · $32.15 in 2025
The $32.15 reported for 2025 was less than what a typical Neuromusculoskeletal Medicine & Omm provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.00 · 2022: $20.50 · 2023: $637 · 2025: $32.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629 · Travel and Lodging: $40.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.53 |
| Travel and Lodging | $40.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $637.00 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $77.00 | 2021 | |
| Microtransponder, INC. | $32.15 | 2025 | |
| Medtronic, INC. | $20.50 | 2022 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferando Testai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.